Clinical Significance of Lymph Node Ratio in Stage III Colorectal Cancer

다국어 초록 (Multilingual Abstract)

Purpose: Recent literature has shown that lymph node ratio is superior to the absolute number of metastatic lymph nodes in predicting the prognosis in several malignances other than colorectal cancer. The aim of this study was to evaluate the prognostic significance of the lymph node ratio (LNR) in patients with stage III colorectal cancer.
Methods: We included 186 stage III colorectal cancer patients who underwent a curative resection over a 10-year period in one hospital. The cutoff point of LNR was chosen as 0.07 because there was significant survival difference at that LNR.
The Kaplan-Meier and the Cox proportional hazard models were used to evaluate the prognostic effect according to LNR.
Results: There was statistically significant longer overall survival in the group of LNR > 0.07 than in the group of LNR ≤ 7(P = 0.008). Especially, there was a survival difference for the N1 patients group (LN < 4) according to LNR (5-year survival of N1 patients was lower in the group of LNR > 0.07, P = 0.025), but there was no survival difference for the N2 group (4≥ LN) according to LNR. The multivariate analysis showed that the LNR is an independent prognostic factor.
Conclusions: LNR can be considered as a more accurate and potent modality for prognostic stratifications in patients with stage III colorectal cancer.

참고문헌 (Reference)

1 Inoue K, "The superiority of ratio-based lymph node staging in gastric carcinoma" 9 : 27-34, 2002

2 Peschaud F, "The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer" 248 : 1067-1073, 2008

3 Astler VB, "The prognostic significance of direct extension of carcinoma of the colon and rectum" 139 : 846-852, 1954

4 Berger AC, "The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma" 70 : 235-240, 2004

5 Schumacher P, "The metastatic lymph node ratio predicts survival in colon cancer" 194 : 827-831, 2007

6 Evans MD, "The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes’ stage B disease" 10 : 157-164, 2008

7 Feinstein AR, "The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer" 312 : 1604-1608, 1985

8 Telian SH, "Significance of the lymph node ratio in stage III colon cancer" 15 : 1557-1558, 2008

9 Persiani R, "Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer" 34 : 519-524, 2008

10 Ceelen W, "Prognostic value of the lymph node ratio in stage III colorectal cancer: a systematic review" 17 : 2847-2855, 2010

11 Weir L, "Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer" 20 : 1793-1799, 2002

12 Lee HY, "Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma" 14 : 1712-1717, 2007

13 Rosenberg R, "Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period" 248 : 968-978, 2008

14 Bando E, "Outcome of ratio of lymph node metastasis in gastric carcinoma" 9 : 775-784, 2002

15 Chin CC, "Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer" 24 : 1297-1302, 2009

16 Wang J, "Lymph node ratio: role in the staging of node-positive colon cancer" 15 : 1600-1608, 2008

17 Baxter NN, "Lymph node evaluation in colorectal cancer patients: a population-based study" 97 : 219-225, 2005

18 Chang GJ, "Lymph node evaluation and survival after curative resection of colon cancer: systematic review" 99 : 433-441, 2007

19 Vather R, "Lymph node evaluation and long-term survival in Stage II and Stage III colon cancer: a national study" 16 : 585-593, 2009

20 Johnson PM, "Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer" 24 : 3570-3575, 2006

21 Herr HW, "Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer" 167 : 1295-1298, 2002

22 Wong SL, "Hospital lymph node examination rates and survival after resection for colon cancer" 298 : 2149-2154, 2007

23 Gajra A, "Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer" 21 : 1029-1034, 2003

24 Kelder W, "Effect of modified Davidson’s fixative on examined number of lymph nodes and TNM-stage in colon carcinoma" 34 : 525-530, 2008

25 Van Cutsem EJ, "Colon cancer: ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up" 19 (19): ii29-30, 2008

26 Le Voyer TE, "Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089" 21 : 2912-2919, 2003

27 Berger AC, "Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes" 23 : 8706-8712, 2005

28 Greene FL, "AJCC cancer staging manual. 6th ed" Springer- Verlag 2002

29 Derwinger K, "A study of lymph node ratio as a prognostic marker in colon cancer" 34 : 771-775, 2008